Transmission of prions

Journal of Infectious Diseases

Volumn 186, Issue SUPPL. 2, 2002, Pages

  Weissmann, Charles ^a,e   Enari, M ^a,b   Klohn P C ^a   Rossi, D ^a,c   Flechsig, E ^a,d  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c UNIVERSITY OF MILAN   (Italy)

^d Inst fur Virologie Immunbiologie   (Germany)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN; PROTEIN; PROTEIN PRP; UNCLASSIFIED DRUG;

CELL CULTURE; CLINICAL FEATURE; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; DISEASE TRANSMISSION; HUMAN; HYPOTHESIS; INFECTION; INFECTION COMPLICATION; ISOMERISM; METAL BINDING; NEUROPATHOLOGY; PRION DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; STERILIZATION REVERSAL; SURFACE PROPERTY;

EID: 0036891080     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/344575     Document Type: Conference Paper

References (111)

1. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347:921-5.
2. Cuille J, Chelle PL. Experimental transmission of trembling to the goat. Comptes Rendus des Séances Acad Sci 1939; 208:1058-160.
3. Gordon WS. Advances in veterinary research - Looping ill, tick-borne fever and scrapie. Vet Rec 1946; 58:516-20.
4. Alper T, Cramp WA, Haig DA, Clarke MC. Does the agent of scrapie replicate without nucleic acid? Nature 1967; 214:764-6.
5. Griffith JS. Serf-replication and scrapie. Nature 1967; 215:1043-4.
6. Prusiner SB. Scrapie prions. Annu Rev Microbiol 1989; 43:345-74.
7. Basler K, Oesch B, Scott M, et al. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 1986; 46:417-28.
8. Oesch B, Westaway D, Wälchli M, et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell 1985; 40:735-46.
9. Stahl N, Baldwin MA, Teplow DB, et al. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 1993; 32:1991-2002.
10. Riek R, Hornemann S, Wider G, Glockshuber R, Wüthrich K. NMR characterization of the full-length recombinant murine prion protein, mPrP (23-231). FEBS Lett 1997; 413:282-8.
11. Pan KM, Baldwin M, Nguyen J, et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 1993; 90:10962-6.
12. Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF, Caughey WS. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 1991; 30:7672-80.
13. Weissmann C. Molecular genetics of transmissible spongiform encephalopathies. J Biol Chem 1999; 274:3-6.
14. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363-83.
15. Büeler H, Aguzzi A, Sailer A, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73:1339-47.
16. Sailer A, Büeler H, Fischer M, Aguzzi A. Weissmann C. No propagation of prions in mice devoid of PrP. Cell 1994; 77:967-8.
17. Fischer M, Rülicke T, Raeber A, et al. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 1996; 15:1255-64.
18. Prusiner SB. Molecular biology of prion diseases. Science 1991; 252:1515-22.
19. Jarrett JT, Lansbury PJ. Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 1993; 73:1055-8.
20. Orgel LE. Prion replication and secondary nucleation. Chem Biol 1996; 3:413-4.
21. Kocisko DA, Come JH, Priola SA, et al. Cell-free formation of protease-resistant prion protein. Nature 1994; 370:471-4.
22. Raymond GJ, Hope J, Kocisko DA, et al. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature 1997; 388:285-8.
23. Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT, Caughey B. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 1995; 375:698-700.
24. Saborio GP, Permanne B. Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411:810-3.
25. Lu BY, Chang JY. Isolation of isoforms of mouse prion protein with PrP(SC)-like structural properties. Biochemistry 2001; 40:13390-6.
26. Jackson GS, Hosszu LL, Power A, et al. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 1999; 283:1935-7.
27. Hill AF, Antoniou M, Collinge J. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J Gen Virol 1999; 80:11-14.
28. Shaked GM, Fridlander G, Meiner Z, Taraboulos A, Gabizon R. Protease-resistant and detergent-insoluble prion protein is not necessarily associated with prion infectivity. J Biol Chem 1999; 274:17981-6.
29. Kaneko K, Ball HL, Wille H, et al. A synthetic peptide initiates Gerstmann-Straussler-Scheinker (GSS) disease in transgenic mice. J Mol Biol 2000; 295:997-1007.
30. Post K, Brown DR, Groschup M, Kretzschmar HA, Riesner D. Neurotoxicity but not infectivity of prion proteins can be induced reversibly in vitro. Arch Virol Suppl 2000; 16:265-73.
31. Prusiner SB, Groth D, Serban A, Stahl N, Gabizon R. Attempts to restore scrapie prion infectivity after exposure to protein denaturants. Proc Natl Acad Sci USA 1993; 90:2793-7.
32. Shaked GM, Meiner Z, Avraham I, Taraboulos A, Gabizon R. Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods. J Biol Chem 2001; 276:14324-8.
33. McKenzie D, Bartz J, Mirwald J, Olander D, Marsh R, Aiken J. Reversibility of scrapie inactivation is enhanced by copper. J Biol Chem 1998; 273:25545-7.
34. Bruce ME, Fraser H, McBride PA, Scott JR, Dickinson AG. The basis of strain variation in scrapie. In: Prusiner SB. Collinge J, Powell J, Anderton B. eds. Prion Diseases of Humans and Animals. New York: Ellis Horwood, 1992:497-508.
35. Birkett CR, Hennion RM, Bembridge DA, et al. Scrapie strains maintain biological phenotypes on propagation in a cell line in culture. Embo J 2001; 20:3351-8.
36. Bessen RA, Marsh RF. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 1994; 68:7859-68.
37. Telling GC, Haga T, Torchia M, Tremblay P, DeArmond SJ, Prusiner SB. Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev 1996; 10:1736-50.
38. Hill AF, Desbruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE. Nature 1997; 389:448-50.
39. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of "new variant" CJD [see comments]. Nature 1996; 383:685-90.
40. Safar J, Wille H, Itri V. et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998; 4:1157-65.
41. Safar J, Cohen FE, Prusiner SB. Quantitative traits of prion strains are enciphered in the conformation of the prion protein. Arch Virol Suppl 2000; 16:227-35.
42. Kimberlin RH, Walker CA. Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. J Gen Virol 1986; 67:255-63.
43. Kimberlin RH, Cole S, Walker CA. Pathogenesis of scrapie is faster when infection is intraspinal instead of intracerebral. Microb Pathog 1987; 2:405-15.
44. Kimberlin RH, Walker CA. Pathogenesis of mouse scrapie: Dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. J Comp Pathol 1979; 89:551-62.
45. Taylor DM, McConnell I, Fraser H. Scrapie infection can be established readily through skin scarification in immunocompetent but not immunodeficient mice. J Gen Virol 1996; 77:1595-9.
46. Maignien T, Lasmezas CI, Beringue V, Dormont D, Deslys JP. Pathogenesis of the oral route of infection of mice with scrapie and bovine spongiform encephalopathy agents. J Gen Virol 1999; 80:3035-42.
47. Prusiner SB, Cochran SP, Alpers MP. Transmission of scrapie in hamsters. J Infect Dis 1985; 152:971-8.
48. Foster JD, Hope J. Fraser H. Transmission of bovine spongiform encephalopathy to sheep and goats. Vet Rec 1993; 133:339-41.
49. Jeffrey M, Ryder S, Martin S, et al. Oral inoculation of sheep with the agent of bovine spongiform encephalopathy (BSE). I. Onset and distribution of disease-specific PrP accumulation in brain and viscera. J Comp Pathol 2001; 124:280-9.
50. Bradley R. Bovine spongiform encephalopathy-distribution and update on some transmission and decontamination studies. In: Gibbs CJ Jr, ed. Bovine Spongiform Encephalopathy - The BSE Dilemma. New York: Springer, 1996:11.
51. Bons N, Mestre-Frances N, Belli P, Cathala F, Gajdusek DC, Brown P. Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc Natl Acad Sci USA 1999; 96:4046-51.
52. Ridley RM, Baker HF. Oral transmission of BSE to primates [letter]. Lancet 1996; 348:1174.
53. Prusiner SB, Scott M, Foster D, et al. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 1990; 63:673-86.
54. Scott M, Groth D, Foster D. et al. Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell 1993; 73:979-88.
55. Crozet C, Bencsik A, Flamant F, Lezmi S, Samarut J, Baron T. Florid plaques in ovine PrP transgenic mice infected with an experimental ovine BSE. EMBO Rep 2001; 2:952-6.
56. Scott MR, Will R, Ironside J, et al. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci USA 1999; 96:15137-42.
57. Mastrianni JA, Capellari S, Telling GC. et al. Inherited prion disease caused by the V210I mutation: Transmission to transgenic mice. Neurology 2001; 57:2198-205.
58. Zeidler M, Stewart G, Cousens SN, Estibeiro K, Will RG. Codon 129 genotype and new variant CJD. Lancet 1997; 350:668.
59. Hunter N, Goldmann W, Marshall E, O'Neill G. Sheep and goats: Natural and experimental TSEs and factors influencing incidence of disease. Arch Virol Suppl 2000; 16:181-8.
60. Raeber AJ, Sailer A, Hegyi I, et al. Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication. Proc Natl Acad Sci USA 1999; 96:3987-92.
61. Montrasio F, Cozzio A, Flechsig E, et al. B lymphocyte-restricted expression of prion protein does not enable prion replication in prion protein knockout mice. Proc Natl Acad Sci USA 2001; 98:4034-7.
62. Enari M, Flechsig E, Weissmann C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc Natl Acad Sci USA 2001; 98:9295-9.
63. Kaneko K, Zulianello L, Scott M, et al. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci USA 1997; 94:10069-74.
64. Lloyd SE, Onwuazor ON, Beck JA, et al. Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci USA 2001; 98:6279-83.
65. Stephenson DA, Chiotti K, Ebeling C, et al. Quantitative trait loci affecting prion incubation time in mice. Genomics 2000; 69:47-53.
66. Manolakou K, Beaton J, McConnell I, et al. Genetic and environmental factors modify bovine spongiform encephalopathy incubation period in mice. Proc Natl Acad Sci USA 2001; 98:7402-7.
67. Thackray AM, Klein MA, Aguzzi A, Bujdoso R. Chronic subclinical prion disease induced by low-dose inoculum. J Virol 2002; 76:2510-7.
68. Hill AF, Joiner S, Linehan J, Desbruslais M, Lantos PL, Collinge J. Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci USA 2000; 97:10248-53.
69. Race R, Raines A, Raymond GJ, Caughey B, Chesebro B. Long-term sub-clinical carrier state precedes scrapie replication and adaptation in a resistant species: Analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans. J Virol 2001; 75:10106-12.
70. Kimberlin RH, Wilesmith JW. Bovine spongiform encephalopathy. Epidemiology, low dose exposure and risks. Ann NY Acad Sci 1994; 724:210-20.
71. Alpers M. Epidemiology and ecology of kuru. In: Prusiner SB, Hadlow W, eds. Slow Transmissible Diseases of the Nervous System. Vol I. New York: Academic Press, 1979:67-92.
72. Race R. Jenny A, Sutton D. Scrapie infectivity and proteinase K-resistant prion protein in sheep placenta, brain, spleen, and lymph node: Implications for transmission and antemortem diagnosis. J Infect Dis 1998; 178:949-53.
73. Ingrosso L, Pisani F, Pocchiari M. Transmission of the 263K scrapie strain by the dental route. J Gen Virol 1999; 80:3043-7.
74. Bolton DC, McKinley MP, Prusiner SB. Identification of a protein that purifies with the scrapie prion. Science 1982; 218:1309-11.
75. Sansonetti PJ, Phalipon A. M cells as ports of entry for enteroinvasive pathogens: Mechanisms of interaction, consequences for the disease process. Semin Immunol 1999; 11:193-203.
76. Kaiserlian D, Etchart N. Entry sites for oral vaccines and drugs: A role for M cells, enterocytes and dendritic cells? Semin Immunol 1999; 11:217-24.
77. Hathaway LJ, Kraehenbuhl JP. The role of M cells in mucosal immunity. Cell Mol Life Sci 2000; 57:323-32.
78. Heppner FL, Christ AD, Klein MA, et al. Transepithelial prion transport by M cells. Nat Meal 2001; 7:976-7.
79. Beekes M, McBride PA. Early accumulation of pathological PrP in the enteric nervous system and gut-associated lymphoid tissue of hamsters orally infected with scrapie. Neurosci Lett 2000; 278:181-4.
80. Prinz M, Montrasio F, Klein MA, et al. Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells. Proc Natl Acad Sci USA 2002; 99:919-24.
81. Bradley R. BSE transmission studies with particular reference to blood. Dev Biol Stand 1999; 99:35-40.
82. Aucouturier P, Geissmann F, Damotte D, et al. Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie. J Clin Invest 2001; 108:703-8.
83. Huang FP, Farquhar CF, Mabbott NA, Bruce ME, MacPherson GG. Migrating intestinal dendritic cells transport PrP(Sc) from the gut. J Gen Virol 2002; 83:267-71.
84. Klein MA, Frigg R, Raeber AJ, et al. PrP expression in B lymphocytes is not required for prion neuroinvasion. Nat Med 1998; 4:1429-33.
85. Montrasio F, Frigg R, Glatzel M, et al. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 2000; 288:1257-9.
86. Mabbott NA, Mackay F, Minns F, Bruce ME. Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nat Med 2000; 6:719-20.
87. Oldstone MB, Race R, Thomas D, et al. Lymphotoxin-alpha- and lymphotoxin-beta-deficient mice differ in susceptibility to scrapie: Evidence against dendritic cell involvement in neuroinvasion. J Virol 2002; 76:4357-63.
88. Beekes M, McBride PA, Baldauf E. Cerebral targeting indicates vagal spread of infection in hamsters fed with scrapie. J Gen Virol 1998; 79:601-7.
89. Bencsik A, Lezmi S, Hunsmann G, Baron T. Close vicinity of PrP expressing cells (FDC) with noradrenergic fibers in healthy sheep spleen. Dev Immunol 2001; 8:235-41.
90. Race R, Oldstone M, Chesebro B. Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: Role of prion protein expression in peripheral nerves and spleen. J Virol 2000; 74:828-33.
91. Brandner S, Raeber A, Sailer A, et al. Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system. Proc Natl Acad Sci USA 1996; 93:13148-51.
92. Blättler T, Brandner S, Raeber AJ, et al. PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 1997; 389:69-73.
93. Raeber AJ, Klein MA, Frigg R, Flechsig E, Aguzzi A, Weissmann C. PrP-dependent association of prions with splenic but not circulating lymphocytes of scrapie-infected mice. Embo J 1999; 18:2702-6.
94. Holada K, Vostal JG, Theisen PW, MacAuley C, Gregori L, Rohwer RG. Scrapie infectivity in hamster blood is not associated with platelets. J Virol 2002; 76:4649-50.
95. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ. Transmission of BSE by blood transfusion in sheep [letter]. Lancet 2000; 356:999-1000.
96. Brown P, Preece M, Brandel JP, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000; 55:1075-81.
97. Brown P. Environmental causes of human spongiform encephalopathy. In: Baker H, Ridley RM, eds. Prion Diseases. Totowa, NJ: Humana Press, 1996:139-54.
98. Bernoulli C, Siegfried J, Baumgartner G, et al. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977; 1:478-9.
99. Gibbs CJ Jr, Asher DM, Kobrine A, Amyx HL, Sulima MP, Gajdusek DC. Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. J Neurol Neurosurg Psychiatry 1994; 57:757-8.
100. Zobeley E, Flechsig E, Cozzio A, Enari M, Weissmann C. Infectivity of scrapie prions bound to a stainless steel surface. Mol Med 1999; 5:240-3.
101. Flechsig E, Hegyi I, Enari M, Schwarz P, Collinge J, Weissmann C. Transmission of scrapie by steel-surface-bound prions. Mol Med 2001; 7:679-84.
102. Williams DF, Askill IN, Smith R. Protein absorption and desorption phenomena on clean metal surfaces. J Biomed Mater Res 1985; 19:313-20.
103. Williams RL, Williams DF. Albumin adsorption on metal surfaces. Biomaterials 1988; 9:206-12.
104. Eckert R, Jeney S, Horber JK. Understanding intercellular interactions and cell adhesion: Lessons from studies on protein-metal interactions. Cell Biol Int 1997; 21:707-13.
105. Bosque PJ, Prusiner SB. Cultured cell sublines highly susceptible to prion infection. J Virol 2000; 74:4377-86.
106. Kanu N, Imokawa Y, Drechsel DN, et al. Transfer of scrapie prion infectivity by cell contact in culture. Curr Biol 2002; 12:523-30.
107. Carrell RW, Lomas DA. Conformational disease. Lancet 1997; 350:134-8.
108. Lansbury PT Jr. Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease. Proc Natl Acad Sci USA 1999; 96:3342-4.
109. Johan K, Westermark G, Engstrom U, Gustavsson A, Hultman P, Westermark P. Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci USA 1998; 95:2558-63.
110. True HL, Lindquist SL. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature 2000; 407:477-83.
111. Chiti F, Webster P, Taddei N, et al. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci USA 1999; 96:3590-4.